US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 22.800
  • 0.0000.00%
Close Jan 8 16:00 ET
  • 23.010
  • +0.210+0.92%
Pre 09:25 ET
2.72BMarket Cap19.32P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
25.33%128.7M
23.23%122.71M
15.40%98.51M
85.90%398.2M
81.98%110.57M
79.39%102.69M
87.49%99.58M
98.12%85.37M
52.10%214.2M
58.60%60.76M
Operating revenue
25.33%128.7M
23.23%122.71M
15.40%98.51M
85.90%398.2M
81.98%110.57M
79.39%102.69M
87.49%99.58M
98.12%85.37M
52.10%214.2M
58.60%60.76M
Cost of revenue
36.07%19.28M
27.90%15.41M
25.88%12.52M
51.10%51.97M
41.21%15.81M
46.58%14.17M
57.60%12.05M
68.86%9.95M
57.16%34.39M
52.35%11.2M
Gross profit
23.61%109.42M
22.58%107.31M
14.01%85.99M
92.56%346.24M
91.19%94.76M
86.05%88.52M
92.52%87.54M
102.75%75.42M
51.17%179.81M
60.08%49.56M
Operating expense
-53.46%58.51M
29.93%53.06M
47.86%58.86M
232.72%259.43M
182.86%53.07M
459.28%125.71M
141.63%40.84M
100.73%39.81M
17.14%77.97M
2.97%18.76M
Selling and administrative expenses
36.71%45.88M
43.44%40.73M
57.94%46.94M
134.23%133.71M
198.38%42.04M
145.88%33.56M
119.82%28.4M
80.88%29.72M
15.03%57.09M
6.51%14.09M
-Selling and marketing expense
34.24%29.11M
43.33%26.25M
42.54%25.32M
194.17%86.69M
269.64%28.93M
185.88%21.68M
151.95%18.31M
161.62%17.76M
--29.47M
--7.83M
-General and administrative expense
41.22%16.78M
43.62%14.48M
80.83%21.62M
70.27%47.02M
109.30%13.1M
95.86%11.88M
78.48%10.08M
24.00%11.95M
--27.62M
--6.26M
Research and development costs
-96.07%3.28M
-24.51%2.99M
-27.54%2.58M
370.72%93.15M
-51.82%1.97M
906.76%83.66M
-0.73%3.95M
4.67%3.56M
16.85%19.79M
-18.01%4.09M
Depreciation amortization depletion
10.11%9.35M
10.08%9.34M
43.07%9.34M
2,865.85%32.57M
1,461.90%9.06M
1,538.42%8.49M
--8.49M
--6.53M
--1.1M
--580K
-Depreciation and amortization
10.11%9.35M
10.08%9.34M
43.07%9.34M
2,865.85%32.57M
1,461.90%9.06M
1,538.42%8.49M
--8.49M
--6.53M
--1.1M
--580K
Operating profit
236.90%50.91M
16.16%54.25M
-23.82%27.13M
-14.75%86.81M
35.36%41.69M
-248.15%-37.19M
63.46%46.7M
105.05%35.61M
94.40%101.84M
141.73%30.8M
Net non-operating interest income expense
1,812.08%4.54M
109.82%3.8M
-265K
1.81M
Total other finance cost
-1,812.08%-4.54M
-109.82%-3.8M
----
----
----
--265K
---1.81M
----
----
----
Other net income (expense)
409.68%1.76M
-2.26M
15.20%1.96M
167.23%7.7M
274.58%8.27M
-162.76%-568K
1,732.26%1.7M
921.63%2.88M
3,008.45%2.21M
Gain on sale of security
409.68%1.76M
---2.26M
----
----
----
---568K
----
----
----
----
Other non- operating income (expenses)
----
----
15.20%1.96M
167.23%7.7M
----
----
----
1,732.26%1.7M
921.63%2.88M
3,008.45%2.21M
Income before tax
250.46%57.21M
15.00%55.79M
-22.04%29.09M
-9.75%94.51M
41.50%46.71M
-246.20%-38.02M
71.75%48.51M
113.72%37.31M
98.83%104.72M
157.61%33.01M
Income tax
283.56%13.32M
39.48%14.99M
-24.93%5.81M
6.75%23.1M
57.40%11.86M
-322.68%-7.26M
62.24%10.75M
83.62%7.75M
64.13%21.64M
115.10%7.54M
Net income
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
Net income continuous Operations
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
Minority interest income
Net income attributable to the parent company
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
Basic earnings per share
227.59%0.37
-2.78%0.35
-28.57%0.2
-16.25%0.67
37.50%0.33
-231.82%-0.29
71.43%0.36
115.38%0.28
110.53%0.8
166.67%0.24
Diluted earnings per share
220.69%0.35
0.00%0.33
-26.92%0.19
-16.00%0.63
40.91%0.31
-245.00%-0.29
65.00%0.33
116.67%0.26
102.70%0.75
144.44%0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 25.33%128.7M23.23%122.71M15.40%98.51M85.90%398.2M81.98%110.57M79.39%102.69M87.49%99.58M98.12%85.37M52.10%214.2M58.60%60.76M
Operating revenue 25.33%128.7M23.23%122.71M15.40%98.51M85.90%398.2M81.98%110.57M79.39%102.69M87.49%99.58M98.12%85.37M52.10%214.2M58.60%60.76M
Cost of revenue 36.07%19.28M27.90%15.41M25.88%12.52M51.10%51.97M41.21%15.81M46.58%14.17M57.60%12.05M68.86%9.95M57.16%34.39M52.35%11.2M
Gross profit 23.61%109.42M22.58%107.31M14.01%85.99M92.56%346.24M91.19%94.76M86.05%88.52M92.52%87.54M102.75%75.42M51.17%179.81M60.08%49.56M
Operating expense -53.46%58.51M29.93%53.06M47.86%58.86M232.72%259.43M182.86%53.07M459.28%125.71M141.63%40.84M100.73%39.81M17.14%77.97M2.97%18.76M
Selling and administrative expenses 36.71%45.88M43.44%40.73M57.94%46.94M134.23%133.71M198.38%42.04M145.88%33.56M119.82%28.4M80.88%29.72M15.03%57.09M6.51%14.09M
-Selling and marketing expense 34.24%29.11M43.33%26.25M42.54%25.32M194.17%86.69M269.64%28.93M185.88%21.68M151.95%18.31M161.62%17.76M--29.47M--7.83M
-General and administrative expense 41.22%16.78M43.62%14.48M80.83%21.62M70.27%47.02M109.30%13.1M95.86%11.88M78.48%10.08M24.00%11.95M--27.62M--6.26M
Research and development costs -96.07%3.28M-24.51%2.99M-27.54%2.58M370.72%93.15M-51.82%1.97M906.76%83.66M-0.73%3.95M4.67%3.56M16.85%19.79M-18.01%4.09M
Depreciation amortization depletion 10.11%9.35M10.08%9.34M43.07%9.34M2,865.85%32.57M1,461.90%9.06M1,538.42%8.49M--8.49M--6.53M--1.1M--580K
-Depreciation and amortization 10.11%9.35M10.08%9.34M43.07%9.34M2,865.85%32.57M1,461.90%9.06M1,538.42%8.49M--8.49M--6.53M--1.1M--580K
Operating profit 236.90%50.91M16.16%54.25M-23.82%27.13M-14.75%86.81M35.36%41.69M-248.15%-37.19M63.46%46.7M105.05%35.61M94.40%101.84M141.73%30.8M
Net non-operating interest income expense 1,812.08%4.54M109.82%3.8M-265K1.81M
Total other finance cost -1,812.08%-4.54M-109.82%-3.8M--------------265K---1.81M------------
Other net income (expense) 409.68%1.76M-2.26M15.20%1.96M167.23%7.7M274.58%8.27M-162.76%-568K1,732.26%1.7M921.63%2.88M3,008.45%2.21M
Gain on sale of security 409.68%1.76M---2.26M---------------568K----------------
Other non- operating income (expenses) --------15.20%1.96M167.23%7.7M------------1,732.26%1.7M921.63%2.88M3,008.45%2.21M
Income before tax 250.46%57.21M15.00%55.79M-22.04%29.09M-9.75%94.51M41.50%46.71M-246.20%-38.02M71.75%48.51M113.72%37.31M98.83%104.72M157.61%33.01M
Income tax 283.56%13.32M39.48%14.99M-24.93%5.81M6.75%23.1M57.40%11.86M-322.68%-7.26M62.24%10.75M83.62%7.75M64.13%21.64M115.10%7.54M
Net income 242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M
Net income continuous Operations 242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M
Minority interest income
Net income attributable to the parent company 242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M
Basic earnings per share 227.59%0.37-2.78%0.35-28.57%0.2-16.25%0.6737.50%0.33-231.82%-0.2971.43%0.36115.38%0.28110.53%0.8166.67%0.24
Diluted earnings per share 220.69%0.350.00%0.33-26.92%0.19-16.00%0.6340.91%0.31-245.00%-0.2965.00%0.33116.67%0.26102.70%0.75144.44%0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday0.00%